Logo image of IVP

INSPIRE VETERINARY PARTNE-A (IVP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IVP - US45784E3045 - Common Stock

0.128 USD
0 (-0.62%)
Last: 12/2/2025, 8:00:02 PM
0.1264 USD
0 (-1.25%)
After Hours: 12/2/2025, 8:00:02 PM
Fundamental Rating

1

IVP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. IVP has a bad profitability rating. Also its financial health evaluation is rather negative. IVP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

IVP had negative earnings in the past year.
In the past year IVP has reported a negative cash flow from operations.
IVP had negative earnings in each of the past 5 years.
IVP had a negative operating cash flow in each of the past 5 years.
IVP Yearly Net Income VS EBIT VS OCF VS FCFIVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -49.85%, IVP is doing worse than 90.10% of the companies in the same industry.
IVP has a worse Return On Equity (-286.48%) than 79.21% of its industry peers.
Industry RankSector Rank
ROA -49.85%
ROE -286.48%
ROIC N/A
ROA(3y)-55.06%
ROA(5y)-37.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVP Yearly ROA, ROE, ROICIVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

IVP has a worse Gross Margin (19.36%) than 60.40% of its industry peers.
IVP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IVP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.18%
GM growth 5YN/A
IVP Yearly Profit, Operating, Gross MarginsIVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

0

2. Health

2.1 Basic Checks

IVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
IVP has more shares outstanding than it did 1 year ago.
IVP has a better debt/assets ratio than last year.
IVP Yearly Shares OutstandingIVP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M
IVP Yearly Total Debt VS Total AssetsIVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

IVP has an Altman-Z score of -3.45. This is a bad value and indicates that IVP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.45, IVP is not doing good in the industry: 89.11% of the companies in the same industry are doing better.
IVP has a Debt/Equity ratio of 2.47. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of IVP (2.47) is worse than 76.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.47
Debt/FCF N/A
Altman-Z -3.45
ROIC/WACCN/A
WACC8.32%
IVP Yearly LT Debt VS Equity VS FCFIVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

IVP has a Current Ratio of 0.39. This is a bad value and indicates that IVP is not financially healthy enough and could expect problems in meeting its short term obligations.
IVP has a Current ratio of 0.39. This is amonst the worse of the industry: IVP underperforms 89.11% of its industry peers.
IVP has a Quick Ratio of 0.39. This is a bad value and indicates that IVP is not financially healthy enough and could expect problems in meeting its short term obligations.
IVP has a Quick ratio of 0.34. This is amonst the worse of the industry: IVP underperforms 89.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.34
IVP Yearly Current Assets VS Current LiabilitesIVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

3

3. Growth

3.1 Past

IVP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.12%, which is quite impressive.
The Revenue has decreased by -8.77% in the past year.
IVP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 86.71% yearly.
EPS 1Y (TTM)98.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.69%
Revenue 1Y (TTM)-8.77%
Revenue growth 3Y86.71%
Revenue growth 5YN/A
Sales Q2Q%6.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVP Yearly Revenue VS EstimatesIVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVP Price Earnings VS Forward Price EarningsIVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVP Per share dataIVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IVP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INSPIRE VETERINARY PARTNE-A

NASDAQ:IVP (12/2/2025, 8:00:02 PM)

After market: 0.1264 0 (-1.25%)

0.128

0 (-0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.37%
Inst Owner Change34.21%
Ins Owners0%
Ins Owner Change0%
Market Cap867.84K
Revenue(TTM)15.56M
Net Income(TTM)-11.94M
AnalystsN/A
Price TargetN/A
Short Float %4.39%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-25.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS2.29
BVpS0.61
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -49.85%
ROE -286.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.36%
FCFM N/A
ROA(3y)-55.06%
ROA(5y)-37.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.18%
GM growth 5YN/A
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 2.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.76%
Cap/Sales 0.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.34
Altman-Z -3.45
F-Score4
WACC8.32%
ROIC/WACCN/A
Cap/Depr(3y)26.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.77%
Revenue growth 3Y86.71%
Revenue growth 5YN/A
Sales Q2Q%6.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-565.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.26%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIRE VETERINARY PARTNE-A / IVP FAQ

Can you provide the ChartMill fundamental rating for INSPIRE VETERINARY PARTNE-A?

ChartMill assigns a fundamental rating of 1 / 10 to IVP.


What is the valuation status for IVP stock?

ChartMill assigns a valuation rating of 0 / 10 to INSPIRE VETERINARY PARTNE-A (IVP). This can be considered as Overvalued.


How profitable is INSPIRE VETERINARY PARTNE-A (IVP) stock?

INSPIRE VETERINARY PARTNE-A (IVP) has a profitability rating of 0 / 10.